Trial Profile
Short-term tolerability of zoledronic acid in Chinese women with postmenopausal osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2013
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions
- 06 Dec 2013 New trial record
- 08 Oct 2013 Results presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.